[Dalamaga M, Diakopoulos KN, Mantzoros CS. The role of adiponectin in cancer: a review of current evidence. Endocr Rev 33, 547–594, 2012.10.1210/er.2011-1015]Search in Google Scholar
[Kubota N, Yano W, Kubota T, Yamauchi T, Itoh S, Kumagai H, Kozono H, Takamoto I, Okamoto S, Shiuchi T, Suzuki R, Satoh H, Tsuchida A, Moroi M, Sugi K, Noda T, Ebinuma H, Ueta Y, Kondo T, Araki E, Ezaki O, Nagai R, Tobe K, Terauchi Y, Ueki K, Minokoshi Y, Kadowaki T. Adiponectin stimulates AMP-activated protein kinase in the hypothalamus and increases food intake. Cell Metab 6, 55–68, 2007.10.1016/j.cmet.2007.06.003]Search in Google Scholar
[Michalakis K, Williams CJ, Mitsiades N, Blakeman J, Balafouta-Tselenis S, Giannopoulos A, Mantzoros CS. Serum adiponectin concentrations and tissue expression of adiponectin receptors are reduced in patients with prostate cancer: a case control study. Cancer Epidemiol Biomarkers Prev 16, 308–313, 2007.10.1158/1055-9965.EPI-06-0621]Search in Google Scholar
[Michalakis KG, Segars JH. The role of adiponectin in reproduction: from polycystic ovary syndrome to assisted reproduction. Fertil Steril 94, 1949–1957, 2010.10.1016/j.fertnstert.2010.05.010]Search in Google Scholar
[Michalakis K. Adiponectin: The “unusual suspect” between insulin resistance and cancer? Prostate Cancer Prostatic Dis 22, 636–637, 2019.10.1038/s41391-019-0142-5]Search in Google Scholar
[Nicolas S, Debayle D, Bechade C, Maroteaux L, Gay AS, Bayer P, Heurteaux C, Guyon A, Chabry J. Adiporon, an adiponectin receptor agonist acts as an antidepressant and metabolic regulator in a mouse model of depression. Transl Psychiatry 8, 159, 2018.10.1038/s41398-018-0210-y]Search in Google Scholar
[Pasquali R, Casanueva F, Haluzik M, van Hulsteijn L, Ledoux S, Monteiro MP, Salvador J, Santini F, Toplak H, Dekkers OM. European Society of Endocrinology Clinical Practice Guideline: Endocrine work-up in obesity. Eur J Endocrinol 182, G1–G32, 2020.10.1530/EJE-19-0893]Search in Google Scholar
[Rifas-Shiman SL, Fleisch A, Hivert MF, Mantzoros C, Gillman MW, Oken E. First and second trimester gestational weight gains are most strongly associated with cord blood levels of hormones at delivery important for glycemic control and somatic growth. Metabolism 69, 112–119, 2017.10.1016/j.metabol.2017.01.019]Search in Google Scholar
[Qi Y, Takahashi N, Hileman SM, Patel HR, Berg AH, Pajvani UB, Scherer PE, Ahima RS. Adiponectin acts in the brain to decrease body weight. Nat Med 10, 524–529, 2004.10.1038/nm1029]Search in Google Scholar
[Seetho IW, Wilding JP. How to approach endocrine assessment in severe obesity? Clin Endocrinol (Oxf) 79, 163–167, 2013.10.1111/cen.12256]Search in Google Scholar
[Wang ZV, Scherer PE. Adiponectin, the past two decades. J Mol Cell Biol 8, 93–100, 2016.10.1093/jmcb/mjw011]Search in Google Scholar